National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

apixaban
An orally active inhibitor of coagulation factor Xa with anticoagulant activity. Apixaban directly inhibits factor Xa, thereby interfering with the conversion of prothrombin to thrombin and preventing formation of cross-linked fibrin clots. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:BMS-562247-01
Chemical structure names:
  • 4'-deoxy-20',20'-difluoro-8'-norvincaleucoblastine ditartrate
  • aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2β,3β,4β,5α,12R,19.alpha.)-, (2R,3R)-2,3-dihydroxybutanedioate (1:2)



Previous:Antrin, Anzemet, apatinib, apaziquone, APC8015F
Next:Aplidin, apolizumab, apomab, apoptosis inducer BZL101, apoptosis inducer GCS-100

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov